The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: -0.75 (-6.67%)
Spread: 1.00 (10.00%)
Open: 11.25
High: 11.50
Low: 10.50
Prev. Close: 11.25
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Stock Options and Total Voting Rights

15 Nov 2022 07:00

RNS Number : 3607G
Tekcapital plc
15 November 2022
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

15th November 2022

 

Tekcapital plc

 ("Tekcapital" or the "Company")

Exercise of Stock Options and Total Voting Rights

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology that can improve people's lives, is pleased to announce that the Company has received notice from Konrad Dabrowski (Non-board CFO) and Max Inglis (General Counsel) to exercise their options to subscribe for 1,100,000 ordinary shares of 0.4 pence each in the Company ("Ordinary Shares") at an exercise price of 7.83p per new Ordinary Share. The notice was accepted and having received the appropriate payment the Company has accordingly issued and allotted the 1,100,000 new ordinary shares (the "Option Shares").

 

Executive

Existing no. of options

Option Shares Exercised

Remaining Share Options Held

 

Shareholding on Admission

Resultant percentage shareholding

Mr. Max Inglis

2,000,000

100,000

1,900,000

1,625,000

1.08%

Mr. Konrad Dabrowski

3,000,000

1,000,000

2,000,000

1,228,000

0.8%

 

Application has been made for the Option Shares to be admitted to trading on the London Stock AIM (the "Admission"). It is expected that Admission will become effective on or around 18th November 2022.

Following the issue of the Option Shares, which on Admission will rank pari passu with the existing ordinary shares, the total number of ordinary shares in issue with voting rights in the Company will be 150,692,328. There are no shares held in treasury.

The above figure of 150,692,328 may therefore be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

1. Max Inglis (General Counsel)

2. Konrad Dabrowski (CFO)

2

 

Reason for the notification

a)

 

Position/status

 

1. General Counsel

2. Chief Financial Officer

b)

 

Initial notification /

Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

TEKCAPITAL PLC

b)

LEI

213800GOJTOV19FIFZ85 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares of 0.4p each

 

ISIN: GB00BKXGY798

 

b)

Nature of the transaction

Exercise of options over new ordinary shares of 0.4 pence each in the Company

c)

 

Price(s) and volume(s)

 

 

 

Director/PDMR

 Price(s)

Volume(s)

Max Inglis

 

7.83p

100,000

Konrad Dabrowski 

7.83p

1,000,000

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

Director/PDMR

 Price(s)

Volume(s)

Max Inglis

 

7.83p

100,000

Konrad Dabrowski 

7.83p

1,000,000

 

e)

 

Date of the transaction

 

14th November 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

LEI: 213800GOJTOV19FIFZ85

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

For further information, please contact:

 

Tekcapital Plc 

Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson / Andrea Seymour / Fergus Mellon

 

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialise, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Tekcapital neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFDFWLEESEFF
Date   Source Headline
3rd Oct 20187:00 amRNSPublication of Research Note
2nd Oct 20187:01 amRNSGuident Ltd Appoints Chairman
2nd Oct 20187:00 amRNSPlacing to raise approximately $1.15million
17th Sep 20187:00 amRNSBelluscura PLC Expands its Patent Portfolio
7th Sep 20187:00 amRNSAppointment of Joint Broker
21st Aug 20182:04 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSMarketing & Technology Transfer Hub
3rd Aug 20187:00 amRNSLucyd Pte Ltd. Launches eShop
1st Aug 20187:00 amRNSSalarius Ltd Appoints CEO
4th Jul 20187:00 amRNSLucyd Pte Ltd. Update
29th Jun 20187:00 amRNSChange of Adviser
30th May 201812:53 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSHolding(s) in Company
22nd May 20187:00 amRNSLucyd Appoints Global Marketing Manager
22nd May 20187:00 amRNSSalarius Ltd Appoints Directors
17th May 20187:00 amRNSPrivate Placement for Belluscura plc
15th May 20181:17 pmRNSHolding(s) in Company
10th May 20187:00 amRNSHolding(s) in Company
8th May 20187:00 amRNSUniversity Technology Commercialization Programme
4th May 20181:45 pmRNSFinal Results
19th Apr 20187:00 amRNSUK Investor Show
1st Mar 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
14th Feb 20187:00 amRNSPrivate Placement for Belluscura to raise US$1.33m
24th Jan 20187:00 amRNSHolding(s) in Company
22nd Jan 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
18th Dec 20174:14 pmRNSHolding(s) in Company
1st Dec 201710:14 amRNSUpdate re. Belluscura IPO
16th Nov 20178:00 amRNSUpdate re. Belluscura IPO
30th Oct 20177:00 amRNSAcquisition of a Patented AI Valet System
28th Sep 20177:00 amRNSPortfolio Company to Raise Funds via a Token Sale
22nd Sep 20177:00 amRNSInvestor Briefing
31st Jul 20177:00 amRNSHalf-year Report
31st May 201711:18 amRNSResult of AGM
31st May 20177:00 amRNSAcquisition of New Gesture Recognition Technology
9th May 20175:13 pmRNSFinal Results
8th May 20179:11 amRNSNotice of AGM
3rd May 20177:00 amRNSPrivate Placement for Belluscura Ltd
2nd May 20179:31 amRNSApp to Search Global University IP
25th Apr 20177:00 amRNSBelluscura acquires Nanotether Discovery Science
20th Mar 20179:11 amRNSHolding(s) in Company
16th Mar 20179:30 amRNSHolding(s) in Company
10th Mar 20179:31 amRNSExercise of Warrants
3rd Mar 20177:00 amRNSBelluscura Launches Passport Medical Device in US
2nd Mar 20177:00 amRNSBelluscura Ltd Launches Slyde in EU
1st Mar 20177:00 amRNSBelluscura Ltd Launches Wire CaddyT In USA
28th Feb 20177:00 amRNSLicense and Development Agreement
15th Feb 20177:00 amRNSAppointment of Joint Broker
2nd Feb 20179:55 amRNSHolding(s) in Company
1st Feb 20175:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.